Skip to main navigation Skip to search Skip to main content

An Open-Label Extension to the B1451027 Protocol to Evaluate the Long-Term Safety and Tolerability of Dimebon (PF-01913539) in Patients with Alzheimer's Disease

Project: Research

Project Details

StatusFinished
Effective start/end date09/1/09 → 08/31/11

Funding

  • Pfizer Incorporated: $14,104.63